Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nur Nicholson currently holds 220,000 shares of Apellis Pharmaceuticals, Inc. (APLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nur Nicholson has been a net seller of APLS stock. They have purchased $0 and sold $2.2M worth of shares.
Nur Nicholson's most recent insider trade was on Sep 7, 2026, when they sold 220,000 shares at $0.00 per share.
Nur Nicholson serves as Executive at Apellis Pharmaceuticals, Inc. (APLS). They have executed 25 insider transactions totaling $2.2M over their tenure at the company.
Nur Nicholson holds the position of Executive at Apellis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Nur Nicholson has shown a selling trading pattern, with $0 in total purchases and $2.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Nur Nicholson was on Jan 16, 2024, when they purchased $1.9M worth of APLS shares. This transaction involved 28,367 shares at $66.30 per share.
Nur Nicholson currently owns 220,000 shares of Apellis Pharmaceuticals, Inc. (APLS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nur Nicholson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nur Nicholson has 25 Form 4 filings on record as an insider at Apellis Pharmaceuticals, Inc..
Set alerts for Nur Nicholson and 40,000+ other insiders.